Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Bookmark and Share
Published: 31 May 2015
Views: 4018
Dr Jan Buckner - Mayo Clinic, Rochester, USA

Dr Buckner talks to ecancertv at ASCO 2015 about a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive function.

Read the news article and watch the press conference for more.

ecancer's filming at ASCO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.